Bullock Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Sell
1,467
-12
-0.8% -$2.8K 0.16% 128
2026
Q1
$361K Buy
1,479
+39
+3% +$9.08K 0.18% 115
2025
Q4
$298K Sell
1,440
-5
-0.3% -$989 0.15% 130
2025
Q3
$269K Buy
1,445
+112
+8% +$19.2K 0.13% 130
2025
Q2
$208K Buy
1,333
+47
+4% +$7.22K 0.11% 145
2025
Q1
$197K Sell
1,286
-1,404
-52% -$220K 0.11% 145
2024
Q4
$389K Sell
2,690
-1,527
-36% -$237K 0.23% 96
2024
Q3
$683K Sell
4,217
-233
-5% -$37.1K 0.41% 60
2024
Q2
$652K Buy
4,450
+15
+0.3% +$2.23K 0.43% 60
2024
Q1
$700K Buy
+4,435
New +$706K 0.47% 56

Other funds holding JNJ

Bullock Wealth Management's JNJ Position: Q2 2026 in Review

Bullock Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.81% in Q2 2026, selling an estimated $2.8K and leaving 1,467 shares worth $373K. The position accounts for 0.16% of the portfolio, ranked #128.

Bullock Wealth Management first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. The position peaked at $700K in Q1 2024. 4,697 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bullock Wealth Management held 1,467 shares of Johnson & Johnson worth $373K as of Q2 2026.
  • Bullock Wealth Management sold 12 Johnson & Johnson shares in Q2 2026, an estimated $2.8K.
  • Johnson & Johnson made up 0.16% of Bullock Wealth Management's portfolio in Q2 2026, its #128 holding.
  • Bullock Wealth Management first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • Bullock Wealth Management's Johnson & Johnson position peaked at $700K in Q1 2024.
  • 4,697 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.